Effective November 1, 2023, FOQUEST is now listed on the Alberta Drug Benefit List for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as a restricted benefit for patients 6 years of age and older. Learn more about the eligibility criteria for reimbursement of Foquest in Alberta.